Laboratory Monitoring in Emicizumab-Treated Persons with Hemophilia A

Muller, J; Pekru, I; Potzsch, B; Berning, B; Oldenburg, J; Spannagl, M

Spannagl, M (reprint author), Ludwig Maximilian Univ Munich, Dept Transfus Med Cell Therapeut & Hemostaseol, Munich, Germany.

THROMBOSIS AND HAEMOSTASIS, 2019; 119 (9): 1384

Abstract

Hemophilia A (HA) is an X-linked hereditary bleeding disorder caused by deficiency of coagulation factor (F) VIII activity. One of the greatest compli......

Full Text Link